Ticker: IRIX

IRIDEX Corporation (NASDAQ: IRIX) has reported its Q1 results for the 2025 fiscal year, showcasing some fluctuations in financial performance. The company operates in the medical device sector, focusing specifically on ophthalmology. Positive Aspects: Total revenues: Increased by 1.1% from $11.7...